Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease, Barrett ’s esophagus, and high-grade dysplasia/esophageal adenocarcinoma
ConclusionSerum metabolite differences can be detected between individuals with GERD versus BE, and between those with BE versus HGD/EA, and may help differentiate patients at different stages of progression to EA.
Source: Metabolomics - Category: Biology Source Type: research
More News: Acid Reflux | Adenocarcinoma | Biology | Cancer | Cancer & Oncology | Eating Disorders & Weight Management | Epidemiology | Esophagus Cancer | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Obesity | Smokers | Study